Alex Haahr Gouliaev
Chief Executive Officer at Atz Holding ApS
Profile
Alex Haahr Gouliaev was the founder of Nuevolution AB, founded in 2001, where he held the title of Chief Executive Officer.
Currently, he is the Chief Executive Officer at Nuevolution A since 2004 and also holds the same title at Atz Holding ApS.
His former job was at NTG Nordic Transport Group A, where he held the position of Director & Director-Chemistry Department from 1996 to 2001.
Dr. Gouliaev received his doctorate degree from the University of Aarhus in 1996 and his graduate degree from the University of Southern Denmark in 1994.
Alex Haahr Gouliaev active positions
| Companies | Position | Start |
|---|---|---|
| Atz Holding ApS | Chief Executive Officer | - |
Nuevolution A/S
 Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Chief Executive Officer | 2004-09-29 |
Former positions of Alex Haahr Gouliaev
| Companies | Position | End |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Director/Board Member | 2000-12-31 |
| NUEVOLUTION AB (PUBL) | Chief Executive Officer | - |
Training of Alex Haahr Gouliaev
| University of Aarhus | Doctorate Degree |
| University of Southern Denmark | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| Private companies | 3 |
|---|---|
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Nuevolution A/S
Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Commercial Services |
| Atz Holding ApS |
- Stock Market
- Insiders
- Alex Haahr Gouliaev
